References
- Lee HY, Lien WC. Effects of COVID-19 vaccine type on Guillain-Barré syndrome: two cases and a literature review. Hum Vaccines Immunother. 2023 Dec 31;19(1):1. doi:10.1080/21645515.2023.2171231.
- Kebayoon A, Wiwanitkit V. Dengue after COVID-19 vaccination: possible and might be missed. Clin Appl Thromb Hemost. 2021 Jan-Dec;27:10760296211047229. doi:10.1177/10760296211047229.
- Joob B, Wiwanitkit V. Letter to the editor: Coronavirus disease 2019 (COVID-19), infectivity, and the incubation period. J Prev Med Public Health. 2020 Mar;53(2):70. doi:10.3961/jpmph.20.065.
- Čiučiulkaitė I, Möhlendick B, Thümmler L, Fisenkci N, Elsner C, Dittmer U, Siffert W, Lindemann M. GNB3 c.825c>T polymorphism influences T-cell but not antibody response following vaccination with the mRNA-1273 vaccine. Front Genet. 2022 Aug 29;13:932043. doi:10.3389/fgene.2022.932043.